Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS1 | P29475 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
| ▸ | DHPS | P49366 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL689417 | 0.93 | — | — | |
| Hydrochloric Acid SCHEMBL27430194 | 0.90 | — | — | |
| Hydrochloric Acid SCHEMBL6777486 | 0.90 | — | — | |
| Guanidine SCHEMBL28317239 | 0.84 | NOS1 (0.43) | NOS1MEN1KMT2AHSD17B10LMNA | |
| Sulfuric Acid SCHEMBL6049591 | 0.79 | BLM (0.50) | NOS1MEN1KMT2AHSD17B10LMNA | |
| Phosphoramidic Acid SCHEMBL2237983 | 0.77 | GGPS1 (0.43) | NOS1MEN1KMT2AHSD17B10NPSR1 | |
| Bromide SCHEMBL3411153 | 0.73 | — | — | |
| SCHEMBL1427863 | 0.73 | — | — | |
| SCHEMBL14577426 | 0.73 | — | — | |
| Hydrochloric Acid SCHEMBL7112164 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114945566-A | Substituted tetrahydrofurans as sodium channel modulators | 沃泰克斯药物股份有限公司 | 2022-08-26 | — | — | CN | disclosed |